Country sequencing, vendor geography, and QP release chains are strategic decisions made, well or poorly, at the US IND stage, long before a company believes it is ready to think globally.
White Paper
Designing a Global IND Strategy Before You Think You Need One
Related Resources
All Resources
case-study
Partnership helped to reduce time to market by ensuring for U.S. based virtual Biopharmaceutical company
Read More
case-study
Process improvements and in-person monitoring help U.S. pharmaceutical company achieve on time for Phase III clinical trials
Read More
post
Exploring Risk-Based Approaches to Raw Material Testing in Pharmaceutical Manufacturing
Read More
post
Potency Assurance for Cellular and Gene Therapy Products
Read More
Let's move from science to success.
Let’s Talk